Catherine Sohn

Title(s)Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address1001 Potrero Avenue, #U585
San Francisco CA 94110
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPharm.D.1977School of Pharmacy
    University of California, San FranciscoResidency1978School of Pharmacy - Pharmacy Practice
    University of PennsylvaniaCertificate of Professional Development2006The Wharton School
    Collapse Awards and Honors
    UCSF2000Distinguished Alumnus
    Healthcare Businesswomens Association2003Woman of the Year
    Licensing Executive Society2009Frank Barnes Mentoring Award
    PharmaVoice2016100 Most Inspiring People in the Life Sciences Industry

    Collapse Overview 
    Collapse Overview
    CATHERINE ANGELL SOHN, Pharm.D., is a pharmacist, adjunct professor, global biopharmaceutical and consumer healthcare executive, and serves on the Boards of public and private life science companies. She is non-executive Chairman of BioEclipse Therapeutics, Inc, a privately held, early clinical stage biotechnology company, and is an independent Director on the Board of Directors of Jazz Pharmaceuticals (NASDAQ: JAZZ), Landec Corp (NASDAQ: LNDC), and Rubius Therapeutics (private). She holds the position of Adjunct Professor at the University of California, San Francisco, School of Pharmacy, and serves on the board of directors of the not-for-profit World Affairs Council of Philadelphia.

    Dr. Sohn has deep biopharmaceutical industry knowledge with thirty years of U.S. and global experience, and a reputation as a strategic thinker with the ability to drive a strong interface between research & development and marketing. She has a passion for the development and introduction of new medicines for patients and diseases with significant unmet needs. Her areas of expertise include strategic product development, business development and introduction of new vaccines, pharmaceutical products and consumer healthcare brands. As an entrepreneur within SmithKline Beecham plc, she started the US Vaccine Business and led the launches of the U.S. Vaccine Business and subsequently led the U.S. introduction of a CNS pharmaceutical product at SmithKline Beecham (now GlaxoSmithKline). Sohn was vice president for worldwide strategic product development from 1994 - 1998, for the cardiovascular, pulmonary and metabolic therapeutic areas at SB plc. Until retiring from GSK in 2010, she was senior vice president for worldwide business development and a member of the global executive team in the GlaxoSmithKline Consumer Healthcare division, responsible for global, US, Japanese and European licensing agreements and acquisitions. She began her biopharmaceutical career in Medical Affairs at SmithKline&French in 1982.

    Sohn earned a PharmD degree from UCSF in 1977 and completed a pharmacy practice residency at UCSF in 1978, before moving to the east coast to join the faculty of the Philadelphia College of Pharmacy and Science (1978 - 1982).

    She received the ‘Distinguished Alumnus’ award from the University of California San Francisco in 2000, was named ‘Woman of the Year’ by the Healthcare Businesswomen’s Association in 2003, received the Licensing Executive Society’s ‘Frank Barnes Mentoring Award’ (2009) and the HBA Euro-Excellence Award (2012). In 2016, she was named one of the PharmaVoice 100 Most Inspiring People in the life-sciences industry, Sohn has authored text book chapters in Applied Therapeutics: The Clinical Use of Drugs and the Handbook of Applied Therapeutics and The Handbook of Non-Prescription Drugs.

    Sohn holds a Certificate of Professional Development from The Wharton School at the University of Pennsylvania, is a Board Leadership Fellow of the National Association of Corporate Directors (NACD), a licensed pharmacist (California) and a Certified Licensing Professional.